The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy
The 24th Annual Meeting of the German Society for Radiation Oncology, Deutschen Gesellschaft fur Radioonkologie (DEGRO), is organized by MCI Deutschland GmbH and will be held during Jun 21 - 24, 2018 at Congress Center Leipzig in Germany. The target audience for this medical event is Radiation Oncologists and Oncologists.
We are very proud to announce that an Honorary Fellowship of the Royal College of Radiologists was awarded to Professor Catharine West, the highest honour that can be bestowed on a non-Fellow of the College, in recognition of exceptional contribution to the speciality of clinical oncology. To read the whole article click here
a REQUITE patient feedback event has been organised in Leicester on May 10th 2018. Patients who participated in the REQUITE observational study in Leicester, their friends and family were invited to attend an evening of talks and discussion about the project and also a newsletter was enclosed on the progress of the study for those who could not make it. 150 Patients and partners registered to attend, a mix of breast and prostate patients.
Led by Professor Catharine West, REQUITE's co-ordinator, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours. The study paves the way for better treatment of prostate cancer. To read the newsitem on AAAS and EurekAlert! click here.
The German Society for Radiation Oncology 24th Annual Meeting 2018 (DEGRO 2018)
REQUITE abstract on hypofractionation among prostate cancer patients has been accepted as an oral presentation.
The 11th annual RGC meeting will take place on the 16th July (8:45-16:30) at the Manchester Cancer Research Centre - Manchester’s newest cancer research facility.
The first day of the Final REQUITE Symposium (17th July, 8:30-17:30, CityLabs) is open to REQUITE consortium members and invited guests. It will have an operational focus.
The Final REQUITE Symposium Dissemination day, (18th July, 9:30-16:15, CityLabs) will celebrate the successes of REQUITE and feedback to stakeholders on the impact of REQUITE and the availability of the REQUITE resource for future research. (Open to all)
ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.
For more information: website
ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.
Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018
Nederlands
English
Français
Deutsch
Italiano
Español